A Digital Microfluidic Platform for the Microscale Production of Functional Immune Cell Therapies
- 20 May 2025
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (21) , 11026-11034
Abstract
Genetically engineering human immune cells has been shown to be an effective approach for developing novel cellular therapies to treat a wide range of diseases. To expand the scope of these cellular therapies while solving persistent challenges, extensive research and development is still required. Here we use a digital microfluidic enabled electroporation system (referred to as triDrop) specifically designed to mitigate harm during electroporation procedures and compare against two state-of-the-art commercially available systems for the engineering of primary human T cells. We describe the ability to use triDrop for highly efficient transfection with minimal reagent consumption while preserving a healthy transcriptomic profile. Finally, we show for the first time the ability to use a digital microfluidic platform for the miniaturized production of Chimeric Antigen Receptor (CAR) T cell therapies demonstrating how this novel system can lead to a 2-fold improvement in immunotherapeutic functionality compared to gold standard methods while providing up to a 20-fold reduction in cost. These results highlight the potential power of this system for automated, rapid, and affordable next-generation cell therapy R&D.Keywords
All Related Versions
Funding Information
- Fonds de Recherche du Qu?bec - Sant?
- MEDTEQ+ (12-E)
- Terry Fox Research Institute (TFRI 1118)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2021-04101)
This publication has 62 references indexed in Scilit:
- Final outcomes analysis of the cell product SQZ‐PBMC‐HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltrationMolecular Carcinogenesis, 2024
- Turnover of PPP1R15A mRNA encoding GADD34 controls responsiveness and adaptation to cellular stressCell Reports, 2024
- A Tri‐Droplet Liquid Structure for Highly Efficient Intracellular Delivery in Primary Mammalian Cells Using Digital MicrofluidicsAdvanced Materials Technologies, 2023
- CAR T cell therapy in solid tumors: A review of current clinical trialseJHaem, 2021
- Microfluidic and Nanofluidic Intracellular DeliveryAdvanced Science, 2021
- Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesCancer Cell, 2020
- Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T CellsCurrent Protocols in Immunology, 2018
- Parameters Affecting Cell Viability Following Electroporation In Vitro2017
- A novel electroporation method using a capillary and wire-type electrodeBiosensors and Bioelectronics, 2008
- Changes of the solution pH due to exposure by high-voltage electric pulsesBioelectrochemistry, 2005